Literature DB >> 32068231

Evaluation of models for predicting the probability of malignancy in patients with pulmonary nodules.

You Li1,2, Hui Hu1, Ziwei Wu1,2, Ge Yan1,2, Tangwei Wu1, Shuiyi Liu1,3, Weiqun Chen2, Zhongxin Lu1,2,3.   

Abstract

OBJECTIVES: The post-imaging, mathematical predictive model was established by combining demographic and imaging characteristics with a pulmonary nodule risk score. The prediction model provides directions for the treatment of pulmonary nodules. Many studies have established predictive models for pulmonary nodules in different populations. However, the predictive factors contained in each model were significantly different. We hypothesized that applying different models to local research groups will make a difference in predicting the benign and malignant lung nodules, distinguishing between early and late lung cancers, and between adenocarcinoma and squamous cell carcinoma. In the present study, we compared four widely used and well-known mathematical prediction models.
MATERIALS AND METHODS: We performed a retrospective study of 496 patients from January 2017 to October 2019, they were diagnosed with nodules by pathological. We evaluate models' performance by viewing 425 malignant and 71 benign patients' computed tomography results. At the same time, we use the calibration curve and the area under the receiver operating characteristic curve whose abbreviation is AUC to assess one model's predictive performance.
RESULTS: We find that in distinguishing the Benign and the Malignancy, Peking University People's Hospital model possessed excellent performance (AUC = 0.63), as well as differentiating between early and late lung cancers (AUC = 0.67) and identifying lung adenocarcinoma (AUC = 0.61). While in the identification of lung squamous cell carcinoma, the Veterans Affairs model performed the best (AUC = 0.69).
CONCLUSIONS: Geographic disparities are an extremely important influence factors, and which clinical features contained in the mathematical prediction model are the key to affect the precision and accuracy.
© 2020 The Author(s).

Entities:  

Keywords:  AUC; evaluation; lung cancer; prediction model; pulmonary nodule

Mesh:

Year:  2020        PMID: 32068231      PMCID: PMC7048676          DOI: 10.1042/BSR20193875

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  35 in total

Review 1.  Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve.

Authors:  Nancy R Cook
Journal:  Clin Chem       Date:  2007-11-16       Impact factor: 8.327

2.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

3.  Using Computer Analysis to Predict Likelihood of Cancer in Lung Nodules.

Authors:  Heber MacMahon
Journal:  Radiology       Date:  2018-01       Impact factor: 11.105

4.  Probability of cancer in pulmonary nodules detected on first screening CT.

Authors:  Annette McWilliams; Martin C Tammemagi; John R Mayo; Heidi Roberts; Geoffrey Liu; Kam Soghrati; Kazuhiro Yasufuku; Simon Martel; Francis Laberge; Michel Gingras; Sukhinder Atkar-Khattra; Christine D Berg; Ken Evans; Richard Finley; John Yee; John English; Paola Nasute; John Goffin; Serge Puksa; Lori Stewart; Scott Tsai; Michael R Johnston; Daria Manos; Garth Nicholas; Glenwood D Goss; Jean M Seely; Kayvan Amjadi; Alain Tremblay; Paul Burrowes; Paul MacEachern; Rick Bhatia; Ming-Sound Tsao; Stephen Lam
Journal:  N Engl J Med       Date:  2013-09-05       Impact factor: 91.245

5.  A mathematical model for predicting malignancy of solitary pulmonary nodules.

Authors:  Yun Li; Jun Wang
Journal:  World J Surg       Date:  2012-04       Impact factor: 3.352

6.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

7.  Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.

Authors:  L Le Marchand; L Sivaraman; L Pierce; A Seifried; A Lum; L R Wilkens; A F Lau
Journal:  Cancer Res       Date:  1998-11-01       Impact factor: 12.701

Review 8.  Lung Cancer Statistics.

Authors:  Lindsey A Torre; Rebecca L Siegel; Ahmedin Jemal
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

9.  Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Authors:  M Patricia Rivera; Atul C Mehta; Momen M Wahidi
Journal:  Chest       Date:  2013-05       Impact factor: 9.410

10.  Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

View more
  3 in total

Review 1.  [Advances and Clinical Application of Malignant Probability Prediction Models for 
Solitary Pulmonary Nodule].

Authors:  Zhaojue Wang; Jing Zhao; Mengzhao Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-08-30

2.  Comprehensive Analysis of Clinical Logistic and Machine Learning-Based Models for the Evaluation of Pulmonary Nodules.

Authors:  Kai Zhang; Zihan Wei; Yuntao Nie; Haifeng Shen; Xin Wang; Jun Wang; Fan Yang; Kezhong Chen
Journal:  JTO Clin Res Rep       Date:  2022-02-22

3.  Solitary pulmonary nodule malignancy predictive models applicable to routine clinical practice: a systematic review.

Authors:  Marina Senent-Valero; Julián Librero; María Pastor-Valero
Journal:  Syst Rev       Date:  2021-12-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.